|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 EUR | -1.12% |
|
-0.37% | +53.23% |
| 2023 | Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | MEDESIS : Invest Securities confirms its recommendation | CF |
Medesis Pharma SA announced that it will receive €999,990 in funding on September 18, 2015. The company will raise funding through crwodfunding platform, Happy Capital. This is pre initial public offering round for the company.
The minimum investment will be €1,800. The company has raised €21,000,000 in total funding from 150 private shareholders till date.
| 1st Jan change | Capi. | |
|---|---|---|
| +53.23% | 6.43M | |
| +5.66% | 111B | |
| +11.23% | 105B | |
| -2.68% | 21.93B | |
| -12.15% | 22.34B | |
| -5.61% | 18.59B | |
| -36.52% | 18.12B | |
| -10.09% | 16.96B | |
| +3.33% | 13.7B | |
| +36.58% | 12.45B |
MEDESIS PHARMA S.A. 
